Q2 Earnings Forecast for ARWR Issued By HC Wainwright
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Analysts at HC Wainwright issued their Q2 2025 earnings estimates for Arrowhead Pharmaceuticals in a research report issued on Wednesday, February 12th. HC Wainwright analyst P. Trucchio anticipates that the biotechnology company will post earnings per share of $2.66 for the quarter. HC Wainwright currently has a […]
